Prevention of Opioid Misuse and Overdose Deaths Among Hispanic/Latinx Adolescents: A Family-based Perspective
NCT06303804 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2026-04-07
Summary
The purpose of this study is to develop culturally-competent family-focused educational modules targeting opioid knowledge and attitudes (including targeting safe storage and prevention of accidental opioid overdose in adolescent populations) and examine changes acceptability, knowledge, and attitudes scores
Conditions
- Opioid Misuse
Interventions
- BEHAVIORAL
-
Educational videos
Participants will be delivered a link to complete demographic information and the initial assessment. Upon completing the (initial) pre-test knowledge assessment, participants will be sent links to the three educational videos staggered across 7 days. Educational videos will determine gaps in knowledge related to opioid use and overdose based on questionnaire responses. Upon the completion of the 7 days, participants will be sent a link to the (final) post-test knowledge assessment to complete.
Sponsors & Collaborators
-
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Alejandra Fernandez, PhD · The University of Texas Health Science Center, Houston
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-02-06
- Primary Completion
- 2024-04-21
- Completion
- 2024-04-21
Countries
- United States
Study Locations
More Related Trials
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program
NCT02120612 ·Status: COMPLETED
-
Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents
NCT00330343 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
NCT05093309 ·Status: COMPLETED ·Phase: NA
-
Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids
NCT05300581 ·Status: COMPLETED ·Phase: NA
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Negating Opioid and Pain Actively Through Intervention
NCT03306147 ·Status: COMPLETED ·Phase: NA
-
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
NCT04091009 ·Status: WITHDRAWN ·Phase: PHASE4
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
European Cohort Study of the Effectiveness of Take Home Naloxone
NCT05072249 ·Status: UNKNOWN
-
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
NCT05463341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
Overdose Risk Management and Naloxone
NCT03933345 ·Status: UNKNOWN
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
NCT00723697 ·Status: COMPLETED
-
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
NCT05307458 ·Status: UNKNOWN
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder
NCT02669901 ·Status: COMPLETED ·Phase: NA
-
RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study
NCT03545321 ·Status: UNKNOWN ·Phase: NA
-
Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study
NCT01151098 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Naltrexone for Overdose Prevention
NCT06633900 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Extended Release Naltrexone for Opioid-Dependent Youth
NCT01843023 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers
NCT01148537 ·Status: COMPLETED ·Phase: PHASE1